Wednesday, October 4, 2017

Even Tougher Choices Ahead for Teva After FDA Shocker

A surprise move from the Food and Drug Administration means that a recovery for Teva Pharmaceutical Industries just got much more difficult.

from WSJ.com: US Business http://ift.tt/2hO10K1
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)